Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQLE | Q14534 | 7/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.76 |
| ▸ | MAPT | P10636 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.74 |
| ▸ | ICMT | O60725 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | FNTA | P49354 | 1/20 | 0.53 |
| ▸ | FNTB | P49356 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5595473 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL18037035 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL8512384 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL9738963 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL17312900 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL2636615 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL19228659 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL1105229 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL5595479 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 | |
| SCHEMBL586128 | 1.00 | SQLE (0.78) | SQLEKMT2AMAPTMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119876059-A | Biological catalytic synthesis method of ambrox | 天津大学浙江研究院(绍兴) | 2025-04-25 | — | — | CN | disclosed |
| WO-2023018326-A1 | SYNTHESIS OF ALKYL TRIAZOLE GLYCOSIDE (ATG) FOR OIL IN WATER APPLICATION | PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) | 2023-02-16 | — | — | WO | disclosed |
| EP-2948245-B1 | PROCESS FOR THE PREPARATION OF 4-METHYLPENT-3-EN-1-OL DERIVATIVES | FIRMENICH & CIE (CH) | 2018-05-30 | — | — | EP | disclosed |
| US-9381507-B2 | Process for the preparation of 4-methylpent-3-en-1-ol derivatives | FIRMENICH SA (CH) | 2016-07-05 | — | — | US | disclosed |
| US-20150353463-A1 | PROCESS FOR THE PREPARATION OF 4-METHYLPENT-3-EN-1-OL DERIVATIVES | FIRMENICH SA (CH) | 2015-12-10 | — | — | US | disclosed |
| EP-2948245-A1 | PROCESS FOR THE PREPARATION OF 4-METHYLPENT-3-EN-1-OL DERIVATIVES | Firmenich SA (CH) | 2015-12-02 | — | — | EP | disclosed |
| WO-2014114615-A1 | PROCESS FOR THE PREPARATION OF 4-METHYLPENT-3-EN-1-OL DERIVATIVES | FIRMENICH SA (CH) | 2014-07-31 | — | — | WO | disclosed |
| US-5155239-A | Preparation of polycyclic ethers | FIRMENICH S.A. (CH) | 1992-10-13 | — | — | US | disclosed |
| US-5155238-A | Acidic cyclization of polyunsaturated, acyclic alcohol or protected alcohol; stereospecific; organoleptic | FIRMENICH S.A. (CH) | 1992-10-13 | — | — | US | disclosed |
| US-5077417-A | Acidifying, cyclizing a polyunsaturated alicyclic alcohol or protected hydroxy group | FIRMENICH SA (CH) | 1991-12-31 | — | — | US | disclosed |
| EP-0403945-A2 | Cycloaliphatic carbinols and their use as starting materials for the preparation of furan derivatives | FIRMENICH SA (CH) | 1990-12-27 | — | — | EP | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4137273-A | INSECTICIDES, CHEMICAL INTERMEDIATES | ZOECON CORPORATION (US) | 1979-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353463-A1 | PROCESS FOR THE PREPARATION OF 4-METHYLPENT-3-EN-1-OL DERIVATIVES | CYP4A11, CYP4B1, CYP51A1 | SQLE 53/4885KMT2A 391/4885MAPT 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.